Singapore, Nov. 12 -- Puerto Rico's transformation into a powerhouse of advanced biopharmaceutical manufacturing is gaining new momentum. In this exclusive interview, Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico, shares insights on how Eli Lilly's landmark expansion is set to shape the island's industrial and human capital landscape. From invigorating supplier networks and academic partnerships to positioning Puerto Rico as a cornerstone of secure, U.S.-aligned drug manufacturing, she discusses the island's strategic rise as a trusted hub for global life sciences.

Theproject is also described as one of the largest private-sector investments in Puerto Rico's history. Beyond job creation, how will this investment streng...